ProductSafer
Subscribe
⚠️

Official Product Recall

This notice was issued by U.S. Food & Drug Administration (FDA).

FDA

Baxter Issues Voluntary Nationwide Recall of Cefazolin in Dextrose Injection, USP, 2G / 100ml(20mg /ml) Single-Dose Infusion Bag in 100ml Due to Particulate Matter Found in Solution

July 24, 2026 – DEERFIELD, Ill., Baxter International Inc. (NYSE:BAX) is voluntarily recalling Lot LD175708, Exp 14-Feb 2027 of Cefazolin in Dextrose Injection due to a report of particulate matter found in the solution identified as cardboard.Risk Statement: The use of the defective product has a

This recall was published by U.S. Food & Drug Administration (FDA). View the full official notice for complete details, affected product codes, and what to do next.

View full recall notice

Get an email when another product is recalled

A free Sunday round-up of new UK and US product recalls and safety warnings. Unsubscribe any time.

What should I do?

  • 1.Stop using the product immediately if you have it.
  • 2.Check the full recall notice for affected batch numbers, UPCs, or model numbers.
  • 3.Follow the instructions in the recall notice for returns, replacements, or disposal.
  • 4.If you have health concerns after using the product, contact your GP or call NHS 111.
Back to all recalls

ProductSafer is not affiliated with the FDA. This page reproduces publicly available recall information.

Never miss a finding

Get the latest health findings delivered to your inbox. Only the important stuff. No spam.

We'll send a confirmation email. Unsubscribe anytime.

Recall: Cefazolin in Dextrose Injection, USP, 2G / 100ml(20mg